Duke Neurology congratulates the graduating residency class of 2020 | Duke Department of Neurology – Duke Department of Neurology

The Duke Neurology residency class of 2020 held their graduation virtually this week, celebrating the completion of their four years of training and contributions to our Department amidst departmental growth, a continuing global pandemic, and numerous other challenges.

Our graduating class of residents will complete their neurology training in fellowships across the field of neurology, both at Duke and in other leading academic institutions across the country.

Congratulations to you all. Youre an amazing class of residents and truly phenomenal doctors. Make yourselves proud of yourselves as we are of you, said Assistant Professor Shreyansh Shah, MD, who shared hosting duties for the graduation. Thanks for selecting us and letting Duke Neurology be a part of your training.

Our graduating residents have selected the following fellowship programs for next year:

The ceremony included a homemade blues song by Associate Professor Emeritus Marvin Rozear, MD, who has been a mainstay of the Neurology Residency program for four decades.

Graduation closed with the presentation of awards to faculty and residents, with winners selected by this years graduating class. Assistant Professor Scott Le, DO, received the 2020 Marvin Rozear Common Sense Award. Assistant Professor Scott Strine, DO, received the 2020 Eun-Lyu Lee Excellence in Teaching Award. Graduating resident Abhi Kapuria, MD, received both the E. Wayne Massey Teaching Award and the Chief Resident Research Award for 2020.

Read more from the original source:
Duke Neurology congratulates the graduating residency class of 2020 | Duke Department of Neurology - Duke Department of Neurology

Coronavirus: What does Covid-19 do to the brain? – BBC News

Image caption Consultant neurologist Arvind Chandratheva points out brain damage on a scan

Stroke, delirium, anxiety, confusion, fatigue - the list goes on. If you think Covid-19 is just a respiratory disease, think again.

As each week passes, it is becoming increasingly clear that coronavirus can trigger a huge range of neurological problems.

Several people who've contacted me after comparatively mild illness have spoken of the lingering cognitive impact of the disease - problems with their memory, tiredness, staying focused.

But it's at the more severe end that there is most concern.

Chatting to Paul Mylrea, it's hard to imagine that he had two massive strokes, both caused by coronavirus infection.

The 64-year-old, who is director of communications at Cambridge University, is eloquent and, despite some lingering weakness on his right side, able-bodied.

He has made one of the most remarkable recoveries ever seen by doctors at the National Hospital for Neurology and Neurosurgery (NHNN) in London.

His first stroke happened while he was in intensive care at University College Hospital. Potentially deadly blood clots were also found in his lungs and legs, so he was put on powerful blood-thinning (anticoagulant) drugs.

A couple of days later he suffered a second, even bigger stroke and was immediately transferred to the NHNN in Queen Square.

Consultant neurologist Dr Arvind Chandratheva was just leaving hospital when the ambulance arrived.

"Paul had a blank expression on his face," he says. "He could only see on one side and he couldn't figure out how to use his phone or remember his passcode.

"I immediately thought that the blood thinners had caused a bleed in the brain, but what we saw was so strange and different."

Paul had suffered another acute stroke due to a clot, depriving vital areas of the brain of blood supply.

Tests showed that he had astonishingly high levels of a marker for the amount of clotting in the blood known as D-dimer.

Normally these are less than 300, and in stroke patients can rise to 1,000. Paul Mylrea's levels were over 80,000.

"I've never seen that level of clotting before - something about his body's response to the infection had caused his blood to become incredibly sticky," says Dr Chandratheva.

During lockdown there was a fall in the number of emergency stroke admissions. But in the space of two weeks, neurologists at the NHNN treated six Covid patients who'd had major strokes. These were not linked to the usual risk factors for stroke such as high blood pressure or diabetes. In each case they saw very high levels of clotting.

Part of the trigger for the strokes was a massive overreaction by the immune system which causes inflammation in the body and brain.

Dr Chandratheva projected Paul's brain images on a wall, highlighting the large areas of damage, shown as white blurs, affecting his vision, memory, coordination, and speech.

The stroke was so big that doctors thought it likely he would not survive, or be left hugely disabled.

"After my second stroke, my wife and daughters thought that was it, they would never see me again," Paul says. "The doctors told them there was not much they could do except wait. Then I somehow survived and have been getting progressively stronger."

One of the first encouraging signs was Paul's ability with languages - he speaks six - and he would switch from English to Portuguese to speak to one of his nurses.

"Unusually he learned several of his languages as an adult, and this will have created different wiring connections in the brain which have survived his stroke," says Dr Chandratheva.

Paul says he cannot read as fast as he used to, and is sometimes forgetful, but that's hardly surprising given the areas of damage in his brain.

His physical recovery has also been impressive, which doctors attribute to his previous very high level of fitness.

"I used to cycle for an hour a day, do a couple of gym sessions a week and swim in the river. My cycling and diving days are over, but I hope to get back to swimming," Paul says.

A study in the Lancet Psychiatry found brain complications in 125 seriously ill coronavirus patients in UK hospitals. Nearly half had suffered a stroke due to a blood clot while others had brain inflammation, psychosis, or dementia-like symptoms.

One of the report authors, Prof Tom Solomon of the University of Liverpool, told me, "It's clear now that this virus does cause problems in the brain whereas initially we thought it was all about the lungs. Part of it is due to lack of oxygen to the brain. But there appear to be many other factors, such as problems with blood clotting and a hyper-inflammatory response of the immune system. We should also ask whether the virus itself is infecting the brain."

Media playback is unsupported on your device

In Canada, neuroscientist Prof Adrian Owen has launched a global online study of how the virus affects cognition. Owen said: "We already know that ICU survivors are vulnerable to cognitive impairment. So as the number of recovered Covid-19 patients continues to climb, it's becoming increasingly apparent that getting sent home from the ICU is not the end for these people. It's just the beginning of their recovery."

"Sars and Mers, which are both caused by coronaviruses, were associated with some neurological disease, but we've never seen anything like this before," Dr Michael Zandi, consultant neurologist at the NHNN, told me. "The closest comparison is the 1918 flu pandemic. We saw then there was a lot of brain disease and problems that emerged over the next 10-20 years."

As the BBC's medical correspondent, since 2004 I have reported on global disease threats such as bird flu, swine flu, Sars and Mers - both coronaviruses - and Ebola. I've been waiting much of my career for a global pandemic, and yet when Covid-19 came along, the world was not as ready as it could have been. Sadly, we may have to live with coronavirus indefinitely. Here, I will be reflecting on that new reality.

A mysterious neurological syndrome known as encephalitis lethargica appeared around the end of World War One and went on to affect more than a million people worldwide. There is limited evidence of its causes, and whether the trigger was influenza or a post-infectious autoimmune disorder.

As well as a sleepiness coma, some patients had movement disorders that looked like Parkinson's disease, which affected them for the rest of their lives.

In his book Awakenings, the neurologist Oliver Sacks told the story of a group of patients who'd been frozen in sleep for decades, and how he used the drug L-Dopa to temporarily free them from their locked-in state.

We should be careful before reading too much into comparisons between Covid-19 and the 1918 Spanish flu pandemic. But with so many Covid patients having neurological symptoms, it will be important to look at the long-term effects on the brain.

Media playback is unsupported on your device

Follow @BBCFergusWalsh on Twitter

Originally posted here:
Coronavirus: What does Covid-19 do to the brain? - BBC News

COVID-19 on the brain: BBC News at the National Hospital for Neurology and Neurosurgery – University College London Hospitals

BBC medical correspondent Fergus Walsh met with NHNN patient Paul Mylrea, 64, who is making a remarkable recovery after suffering two major strokes triggered by COVID-19 infection.

Im very lucky in physical terms but it has been tough, said Paul who had previously been very healthy and active and had a passion for diving.

After my second stroke, my wife and daughters thought that was it, they would never see me again. The doctors told them there was not much they could do except wait. Then I somehow survived.

Pauls first stroke was caused by a blood clot in his brain and happened while he was recovering from COVID-19 at University College Hospital. The clinical team also found blood clots in his lungs and legs so prescribed powerful blood-thinning drugs.

A couple of days later, however, he suffered a second, even bigger stroke and was transferred to the NHNN for specialist care.

Pauls consultant neurologist, Dr Arvind Chandratheva, said: I immediately assumed the blood-thinning drugs had caused a bleed in the brain but what we discovered was unlike anything we have seen before.

Despite the blood-thinning treatment, Pauls second stroke had been caused by another clot in his brain and blood tests showed that he had extraordinarily high levels of a clotting marker called D-dimer. Normally these levels are less than 300 and can rise to 1,000 in stroke patients but in Pauls case they were 80,000.

"I've never seen that level of clotting before something about his body's response to the COVID-19 infection had caused his blood to become incredibly sticky," said Dr Chandratheva.

It puzzled us why a fit and healthy man had experienced so many blood clots in rapid succession, despite blood-thinning treatment. But in just two weeks in April 2020, our team saw six people with COVID-19 who had similar strokes caused by a blocked, large artery in the brain.

We were witnessing the unfolding of a distinctive pattern of stroke associated with the pandemic.

Specialists at the NHNN have also seen an increase in COVID-19 patients with extensive inflammation in the brain. They do not think this is caused by COVID-19 itself but by the bodys immune system overreacting to the disease.

Consultant neurologist Dr Michael Zandi said: We are starting to see a number of effects of COVID-19 on the brain which are very concerning. For some people it could be devastating and life-altering.

We need to be prepared for decades of impact on peoples brains and mental health. The closest comparison we have is the 1918 flu pandemic when a lot of brain disease and problems emerged over the following 10 to 20 years."

Paul, who is a leading communications professional and speaks six languages, spent five weeks in hospital but is now recovering extremely well at home.

In the BBC report, we see Paul having online neurorehabilitation with clinical psychologist Dr Catherine Doogan and occupational therapist Kate Kelly as part of the N-ROL programme. The programme is led by Professor Nick Ward and supported by fundraising efforts by the charity SameYou to allow people to continue with their rehabilitation at home during the pandemic.

Paul said: I have been getting progressively stronger thanks to the ongoing care of the NHNN.

Here is the full news report, online articleand podcast(at 22m 20s).

For further information also see an article featuring Dr Chandratheva in The Conversation.

Continued here:
COVID-19 on the brain: BBC News at the National Hospital for Neurology and Neurosurgery - University College London Hospitals

Neurology Study: Contact Sports and Concussion in Rugby – LWOR – Last Word On Rugby

In a study that compared Rugby Players to Swimmers and Rowers, study author Ravi S. Menon, Ph.D., FRSC, of Western University in London, Canada, found that contact sports have a correlation with brain damage and concussion.

According to a new study published in the June 17, 2020, online issue of Neurology, the medical journal of theAmerican Academy of Neurology, the study compared rugby players to other female college athletes competing in the non-contact sports of swimming and rowing.

101 female college athletes took part in the study. This included 70 rugby players and 31 rowing or swimming athletes. The study followed a subset of the rugby players for at least two years. It also followed swimmers and rowers for one year.

In terms of rugby union, the fact that the tackler and the tackled player are at risk, is well established. What this study has found is that exposure at any level, can result in changes to a player [subject] microstructure of the white matter, including in nerve fibers that connect areas of the brain. This white matter controls basic emotions like fear, pleasure, and anger. In some of the rugby players, the changes progressed over time.

While any contact sport such as football, basketball, and American Football may result in injury. Rugby, with players intent to stop the forward progress of the opposition, putting bodies and especially heads, in a compromised position (in the contact area). These results indicate that only after a short term, affects can be found more in rugby union. More so than in non-contact sports.

Even with no concussions, the repetitive impacts experienced by the rugby players [even during training] clearly had effects on the brain, said Menon.

Researchers used magnetic resonance imaging (MRI) to scan the brains of all the athletes during in- and off-season play. With the brain scans, researchers examined how water molecules moved throughout the white matter. This was to determine if there were microstructural brain changes.

Researchers found differences in the functional organization of the brain too. When compared to swimmers and rowers, rugby players had changes in connectivity. How the brain communicates between the areas of the brain that control memory retrieval and visual processing.

While we only looked at these impacts during a few events during the season, previous research has shown these kinds of subclinical impacts may accumulate over years of participation in contact sports.

More research is needed to understand what these changes may mean and to what extent they reflect how the brain compensates for the injuries, repairs itself or degenerates so we can better understand the long-term health effects of playing a contact sport.

With growing evidence of new and established studies, many will conclude that the game is counter-productive. The risk is too large. Current players will, and continue to suffer from injury due to contact sports activity.

HIA tests today are risk-averse, to remove any player from harm. This head injury assessment can mean the difference between a serious injury and player welfare. Although, the results of the study by Western University prove that any exposure is harmful.

Head injury protocols have been issued by World Rugby. Players should aim to lower the tackle area. Promoting less impact that includes the head area should improve the welfare of players. Yet at the center of the argument is, that it is the choice of the individual.

In time, rule variations, reduced emphasis in the breakdown, changes to contact sports like rugby may alter the sport. But, the focus will and should focus on health and welfare first.

___________________________________

The study was supported by the Schulich School of Medicine & Dentistry at Western University, the Canadian Institutes for Health Research, Brain Canada, Canada First Research Excellence Fund, and the Natural Sciences and Engineering Research Council of Canada.

Main photo creditEmbed from Getty Images

More:
Neurology Study: Contact Sports and Concussion in Rugby - LWOR - Last Word On Rugby

Higgins announces $2.2 million grant to UB to support Parkinson’s research – UB Now: News and views for UB faculty and staff – University at Buffalo…

Rep. Brian Higgins has announced that UB has received a five-year, $2,224,925 grant from the National Institutes of Health to develop a method to diagnose Parkinsons disease (PD) before clinical symptoms are present.

The funding was awarded by the National Institute of Neurological Disorders and Stroke of the NIH. Principal investigator is Jian Feng, professor of physiology and biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB.

Parkinsons is a motor system disorder resulting from the loss of dopamine-producing cells in the brain. It currently is diagnosed by neurologists observing and rating clinical symptoms based on a standard criteria. To even exhibit the onset of clinical symptoms of PD, one must experience many decades of cellular deterioration.

UBsresearch aims to transform Parkinsons research and therapeutic development with the ability to diagnose PD earlier, allowing for the possibility of proactively preventing or delaying severe neuron decay. The research, titled Molecular Segregation of Parkinsons Disease by Patient derived Neurons will also aim to identify and separate two major subtypes of PD those who experience tremors and those who do not to be able to better treat specific types of PD.

The National Institutes of Health estimates that up to 1 million people in the United States may have Parkinsons disease. Thats 1 million Americans with a difficult, progressive condition without a cure who must wait until their clinical symptoms are serious enough to be diagnosed, Higgins said. This federal investment to assist our Western New York researchers hopes to provide a path to earlier detection of Parkinsons to attempt treatment as quick as possible.

When we generated induced pluripotent stem cells from a group of Parkinsons disease patients and a group of normal subjects, we found that there were many significant differences in the expression levels of genes controlling the production, utilization and degradation of dopamine, Feng said. Thus, we want to investigate this further with the goal of developing a method for the objective diagnosis of Parkinsons disease. It might also allow us to predict years in advance who may develop Parkinsons.

Higgins has been an advocate for measures that advance Parkinsons research and treatment.Following meetings with the Michael J. Fox Foundation,the Parkinsons Foundation of WNY and local advocate and former congressman Jack Quinn, Higgins sent a letter to the Department of Veterans Affairs and the Department of Health and Human Services last January urging that access to boxing therapy in the treatment of Parkinsons be expanded, as well as more research be conducted to document the efficacy of the program.In February, he drafted a bipartisan letter supporting funding for a surveillance database at the Centers for Disease Control and Prevention to collect vital demographic information on people living with neurological diseases,a measure supported by the Michael J. Fox Foundation.

Go here to see the original:
Higgins announces $2.2 million grant to UB to support Parkinson's research - UB Now: News and views for UB faculty and staff - University at Buffalo...

Chiesi Licenses Bioasis Tech to Tackle Brain Symptoms of Rare Diseases – Xconomy

XconomyBoston

The blood-brain barrier protects the functioning of that essential organ, but its also a hurdle to delivering neurological drugs.

Italys Chiesi Group has agreed to pay Guilford, CT-based Bioasis Technologies $3 million up front to use the preclinical firms technology to facilitate the delivery of enzymes across the blood-brain barrier to treat neurological symptoms associated with four lysosomal storage disorders (LSDs). Such diseases are caused by mutations in the genetic instructions for important enzymes that normally help our cells clear out waste. Without those enzymes, toxic materials build up in the bodys cells over time.

Under the agreement Chiesi is responsible for R&D and commercialization costs associated with the programs. Bioasis is eligible for up to $138 more in milestone payments, plus royalties on net sales of any product Chiesi commercializes using its technology. In exchange Chiesi gets the rights to what Bioasis calls its xB3 platform, the technology the company is developing for the delivery of therapeutics across the blood-brain barrier and the treatment of central nervous system disorders.

Bioasis says its xB3 technology uses a process called receptor-mediated transcytosis and a human transport protein, melanotransferrin, to move molecules across the blood-brain-barrier. The company says that in preclinical studies, this method was able to ferry molecules of varying sizes and types into the brain.

Enzyme replacement therapy is used to treat some LSDs, but neurological complications of the disorders remain largely unaffected even when other affected parts of the body respond to the treatment, according to Bioasis CEO Deborah Rathjen.

The unique delivery method of [Bioasiss] xB3 platform has the potential to overcome a significant challenge in the treatment of many neurological disorders, which is the ability to cross the blood-brain barrier, said Giacomo Chiesi, who heads the companys Boston-based rare disease unit Chiesi, which launched in February.

The BioMarin Pharmaceuticals (NASDAQ: BMRN) drug erliponase alfa (Brineura), for example, which was approved in 2017 to treat a group of degenerative neurometabolic disorders caused by an enzyme deficiency, must be administered directly into the brain through a stent.

Chiesi isnt disclosing the specific LSDs it is targeting. Nearly 50 exist, according to the National Organization for Rare Disorders. For most LSDs no or few treatment options exist.

The companies described their new partnership as a strategic alliance focused on rare diseases.

Sarah de Crescenzo is an Xconomy editor based in San Diego. You can reach her at sdecrescenzo@xconomy.com.

Read the rest here:
Chiesi Licenses Bioasis Tech to Tackle Brain Symptoms of Rare Diseases - Xconomy

How does research in biochemistry fit into the wider goals of the NIH? – Open Access Government

Established in 1962, the National Institute of General Medical Sciences (NIGMS) supports basic research that increases understanding of biological processes while also laying the foundation for advances in disease diagnosis, treatment, and prevention in the U.S. NIGMS is headed by Director Jon R. Lorsch who oversees the Institutes $2.6 billion budget, which supports this research.

NIGMS supports more than 3,000 investigators and 4,500 research grants around 11% of the total number of research grants funded by the National Institutes of Health (NIH) as a whole. Additionally, it supports around 26% of the National Research Training Award (NRSA) trainees who receive assistance from NIH. It is organised into divisions that support research and research training in a range of different fields.

From 2018 onwards, NIGMS reorganised into three scientific divisions specifically: Biophysics, Biomedical Technology, and Computational Biosciences (BBCB); Genetics and Molecular, Cellular and Developmental Biology (GMCDB); and Pharmacology, Physiology, and Biological Chemistry (PPBC).

The latter of these divisions supports a broad spectrum of state-of-the-art research aimed at improving the molecular-level understanding of fundamental biological processes and discovering approaches to their control. Just some of the goals of this supported research include an improved understanding of drug action and of anaesthesia; mechanisms underlying responses to drugs; new methods and targets for drug discovery; an enhanced understanding of biological catalysis; knowledge of metabolic regulation and fundamental physiological processes; and the integration and application of basic physiological, pharmacological, and biochemical research to clinical issues in anaesthesia, clinical pharmacology, and trauma and burn injury.

The division itself has two components: The Biochemistry and Bio-related Chemistry Branch and the Pharmacological and Physiological Sciences Branch.

It is important to recognise the fundamentals of each branches focal point and what their individual goals are. Understanding the interactions between molecules thats chemistry. And understanding the chemistry that occurs in living organisms, however thats biochemistry. Furthermore, understanding how medicines work in the body and finding ways to make them work better and more effectively thats pharmacology. Studies in these areas are currently focussing on areas such as:

How enzymes generate cellular energy and facilitate chemical reactions.

How medicines are processed inside the body.

What roles natural substances such as fats and sugars play in our bodies.

How a persons genetic makeup can influence a drugs effectiveness.

How to use chemistry to design new medicines.

The possibility of finding new uses for existing medicines.1

The Biochemistry and Bio-related Chemistry Branch supports basic research in the following areas:

Continued here:
How does research in biochemistry fit into the wider goals of the NIH? - Open Access Government

Automatic Veterinary Biochemistry Analyzer Market Analysis with Impact of COVID-19 on Growth Opportunity by 2024 – 3rd Watch News

The Research Report on Automatic Veterinary Biochemistry Analyzer Market is a Skillful and Deep Analysis of the Present Situation and Challenges. Experts have studied the historical data and compared it with the current market situation. The Research Report covers all the necessary information required by new market entrants as well as the existing players to gain a deeper insight into the market.

The Automatic Veterinary Biochemistry Analyzer Market Research study relies upon a combination of primary as well as secondary research. It throws light on the key factors concerned with generating and limiting Automatic Veterinary Biochemistry Analyzer Market growth. In addition, the current mergers and acquisition by key players in the market have been described at length. Additionally, the historical information and growth in the CAGR have been given in the research report. The latest trends, product portfolio, demographics, geographical segmentation, and regulatory framework of the Automatic Veterinary Biochemistry Analyzer market have also been included in the study.

Below mentioned companies are analyzed upon their revenue, price margins in the market and main products they offer: Biochemical Systems International, BPC BioSed, Carolina Liquid Chemistries, Abaxis Europe, AMS Alliance, Randox Laboratories, Rayto Life and Analytical Sciences, Scil Animal Care, Crony Instruments, DiaSys Diagnostic Systems, Eurolyser Diagnostica, Gesan Production, Heska, Idexx Laboratories, LITEON IT Corporation, Shenzhen Icubio Biomedical Technology, URIT Medical Electronic

Click Here To Access The Sample Report: https://www.acquiremarketresearch.com/sample-request/366879/

Covid-19 pandemic affects most industries in the globe. Here at acquire market research we offer you comprehensive data of related industry which will help and support your business in all possible ways.

Market segment by product type, split into Bench-Top Veterinary Biochemistry Analyzer, Portable Veterinary Biochemistry Analyzer along with their consumption (sales), market share and growth rate.

Market segment by application, split into Pet Hospital, Veterinary Station along with their consumption (sales), market share and growth rate.

This study gives data on patterns and improvements, and spotlights on Markets and materials, limits and on the changing structure of the Automatic Veterinary Biochemistry Analyzer Industry. The key motivation behind the report is to give a proper and key examination of this industry.

To Get This Report At Beneficial Rates: https://www.acquiremarketresearch.com/discount-request/366879/

As a part of our Corporate Social Responsibility, we would like to announce that we would be contributing 15 % of our profits to USA, UK, Italy, Spain and India relief fund.

Reasons to invest in this report:1. To gain a thorough understanding of the global market.2. To determine the latest trends and projected growth rate over the forecast period.3. To assist industry specialists, market investors, and other stakeholders line up their market-centric strategies.4. To acquire well-informed business decisions and gain insights from presentations and marketing material.5. To conduct a competitive analysis of major market participants.

What does the report cover with respect to the regional landscape of the market?

1. The Automatic Veterinary Biochemistry Analyzer Market report, with respect to the geological spectrum of this scope, analyzes examines each geographical segment of the market with supply, import, export, consumption, and production in these regions to provide a complete understanding of the market, covering, {{United States, Europe, China, Japan, Other Regions}}

2. Basic information with detail to the market share held by the regions in company with the trade, deal, that every geography explanations for have been given in the report. Our business offerings show fresh and trustworthy information helpful for businesses to give strength to a competitive edge.

Browse Full [emailprotected] https://www.acquiremarketresearch.com/industry-reports/automatic-veterinary-biochemistry-analyzer-market/366879/

Moreover, the report includes analysis of different products available in the Automatic Veterinary Biochemistry Analyzer market on the subject of production volume, revenue, pricing structure, and demand and supply figures. The report highlights profitable business strategies of market competitors along with their business expansion, composition, partnership deals, and new product/service launches.

About us:

Acquire Market Research is a market research-based company empowering companies with data-driven insights. We provide Market Research Reports with accurate and well-informed data, Real-Time with Real Application. A good research methodology proves to be powerful and simplified information that applied right from day-to-day lives to complex decisions helps us navigate through with vision, purpose and well-armed strategies. At Acquire Market Research, we constantly strive for innovation in the techniques and the quality of analysis that goes into our reports.

Contact Us:

Sally Mach555 Madison Avenue,5th Floor, Manhattan,New York, 10022 USAPhone No: +1 (800) 663-5579Email ID: [emailprotected]

Here is the original post:
Automatic Veterinary Biochemistry Analyzer Market Analysis with Impact of COVID-19 on Growth Opportunity by 2024 - 3rd Watch News

COVID-19 Impact on Global Biochemistry Analyzer Industry 2020: Industry Trends, Size, Applications, SWOT Analysis by Top Key Players and Forecast…

Biochemistry Analyzer IndustryReport is designed to provide Industry Experts and Investors with detail overview of Biochemistry Analyzer Industry report, which will help them to take decisions with respect to Key Players, Regions, Manufacturers, Types and Trend etc.

This report gives a detail insight for a period of 2018-2025 Research Report. The market size estimations have been provided in terms of value (USD million).

Get Sample Copy of this Report at https://www.orianresearch.com/request-sample/590363

TheGlobal Biochemistry Analyzer Marketis expected to grow USD XX Million by 2025 at a CAGR of around 5.9% during the forecast period, 2018-2025. Biochemistry analyser can chemicals in biological samples. These analyzers focuses on analytes such as electrolytes, drugs of abuse, specific proteins, enzyme, and metabolite tests for cardiac, liver, and renal function.

Top Key Players Analyzed in Global Biochemistry Analyzer Market are Siemens AG Thermo Fisher Scientific, Inc. Randox Laboratories Ltd. Abbott, Danaher Corporation F.Hoffman-La Roche Ltd. Meril, Hologic Inc. Beckman Coulter Inc. Horiba Medical

The market size estimations have been provided in terms of value (USD million). The global Biochemistry Analyzer industry report also identifies major market players and provides analysis in terms of company overview, Financials, products & services, market trends, recent developments and growth strategies.

Regionally, North America, Latin America, Europe, Asia Pacific, And the Middle East & Africa constitute the key market segments.

Complete report on Biochemistry Analyzer Industry spread across 121 pages, profiling 8 companies and supported with tables and figures. For more details Enquire @https://www.orianresearch.com/enquiry-before-buying/590363

Theglobal Biochemistry Analyzer marketis anticipated to show significant growth during the forecast period. This growth can be attributed to rising incidence of diseases and rapidly growing demand for diagnostic tests. Due to a increase in the disposable income, the number of people with insurance has also increased, giving them accessibility to private labs that have high-end diagnostic instruments. However, high cost of diagnostic tests is key factor projected to curb the market growth over the forecast period.

Biochemistry analyzer have wide applications in Clinical Diagnostics, Drug Development Applications, Bioreactor By Product Detection and Others. clinical diagnostics segment was the leading segment and it accounted for largest share of total revenue generated in 2017. The drug development applications segment is forecast to be the second most lucrative segment in the global biochemistry analyzers market

Key Benefit Of This Report: Global, Regional, Country, Application, and TECHNOLOGY Market Size and Forecast from 2014-2025 Provide attractive market segments and associated growth opportunities Detailed market dynamics, industry outlook with market specific PESTLE, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies Identification of key companies that can influence this market on a global and regional scale Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies Detailed insights on emerging regions, product & application, and competitive landscape with qualitative and quantitative information and facts

Get Direct Copy of this Report @https://www.orianresearch.com/checkout/590363

In terms of revene, North America held large chunk of market share in 2017 on account of presence of developed healthcare infrastructure. In 2017, Europe was the second largest regional market in terms of revenue. Asia pacific is expected to witness rapid growth within the forecast period owing to increasing demand from China, Japan, and India.

Major Points Covered in Table of Contents:1 Executive Summary2 Methodology And Market Scope3 Infiniband Market Industry Outlook4 Biochemistry Analyzer Market Type Outlook5 Biochemistry Analyzer Market Application Outlook6 Biochemistry Analyzer Market Regional Outlook7 Competitive Landscape

Customization Service of the Report:

Orian Research provides customisation of reports as per your need. This report can be personalised to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About Us:

Orian Researchis one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:

Ruwin Mendez

Vice President Global Sales & Partner RelationsOrian Research ConsultantsUS: +1 (832) 380-8827 | UK: +44 0161-818-8027Email:[emailprotected]

Website:www.orianresearch.com/

See the rest here:
COVID-19 Impact on Global Biochemistry Analyzer Industry 2020: Industry Trends, Size, Applications, SWOT Analysis by Top Key Players and Forecast...

Veterinary Biochemistry Analyzers Market to Witness Robust Expansion Throughout the Forecast Period 2020 2027: Abaxis Europe, AMS Alliance,…

The Global Veterinary Biochemistry Analyzers Market Research Report provides customers with a complete analytical study that provides all the details of key players such as company profile, product portfolio, capacity, price, cost, and revenue during the forecast period from 2020 to 2027. The report provides a full assessment. Veterinary Biochemistry Analyzers market with future trends, current growth factors, meticulous opinions, facts, historical data and statistically supported and industry-validated market data.

This Veterinary Biochemistry Analyzers market research provides a clear explanation of how this market will impress growth during the mentioned period. This study report scanned specific data for specific characteristics such as Type, Size, Application and End User. There are basic segments included in the segmentation analysis that are the result of SWOT analysis and PESTEL analysis.

Request Sample PDF of Veterinary Biochemistry Analyzers Market Report:https://www.worldwidemarketreports.com/sample/123906

Abaxis Europe, AMS Alliance, Biochemical Systems International, BPC BioSed, Carolina Liquid Chemistries, Crony Instruments, DiaSys Diagnostic Systems, Eurolyser Diagnostica, Gesan Production, Heska, Idexx Laboratories, LITEON IT Corporation, Randox Laboratories, Rayto Life and Analytical Sciences, Scil Animal Care, Shenzhen Icubio Biomedical Technology are some of the major organizations dominating the global market.(*Note: Other Players Can be Added per Request)

Key players in the Veterinary Biochemistry Analyzers market were identified through a second survey, and their market share was determined through a primary and second survey. All measurement sharing, splitting, and analysis were solved using a secondary source and a validated primary source. The Veterinary Biochemistry Analyzers market report starts with a basic overview of the Industry Life Cycle, Definitions, Classifications, Applications, and Industry Chain Structure, and when used together, how key players can meet market coverage, offered characteristics, and customer needs It helps to understand.

The report also makes some important suggestions for new Veterinary Biochemistry Analyzers market projects before evaluating their feasibility. Overall, this report covers Veterinary Biochemistry Analyzers market Sales, Price, Sales, Gross Profit, Historical Growth,and Future Prospects. It provides facts related to the widespread merger, acquisition, partnership, and joint venture activities on the market.

This report includes market size estimates of value (million US $) and trading volume (K MT). The top-down and bottom-up approaches are used to estimate and validate the market size of the Veterinary Biochemistry Analyzers market, estimating the size of various other subordinate markets in the overall market. All ratio sharing, splitting, and analysis were determined using the secondary source and the identified primary source.

What Veterinary Biochemistry Analyzers Market report offers:

Remarkable Attributes of Veterinary Biochemistry Analyzers Market Report:

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends.

Contact Us:

Mr. ShahWorldwide Market ReportsSeattle, WA 98154,U.S.Email: [emailprotected]

Here is the original post:
Veterinary Biochemistry Analyzers Market to Witness Robust Expansion Throughout the Forecast Period 2020 2027: Abaxis Europe, AMS Alliance,...

Global Biochemical Reagents Market Top Key Players, Regions, Type and Application Outlook Upto 2020 to 2025 – 3rd Watch News

Global Biochemical Reagents Market 2020-2025 Research Report is spread throughout 100+ pages and offers exclusive important statistics, informative data, key traits and competitive landscape details on this area of interest sector.

Global Biochemical Reagents Market report offers the significant statistics to assist the corporations to cope up with the understanding gap due to the advancements within the enterprise and successfully utilize the possibilities that gift itself into the ever-converting market.

Attributes and market execution have investigated the use of quantitative and qualitative strategies to give a clear photograph of cutting-edge and future boom trends. A unique market analysis based totally on geographic locations is also provided in Biochemical Reagents industry record. The international Biochemical Reagents Market report offers the statistics diagrams, figures, and collateral that illustrates the country of the particular trade within the local and global scenario.

Download FREE Sample PDF (including full TOC, Tables and Figures) of Biochemical Reagents Market @ https://www.eonmarketresearch.com/sample/72747

Top Manufacturers Listed in the Biochemical Reagents Market Report are: Agilent Technologies, Inc., Roche Holding AG, Thermo Fisher Scientific Inc., Johnson and Johnson, BD, Merck and Co. Inc., Waters Corporation, Siemens Healthineers, Bio-Rad Laboratories, Abbott Laboratories.

The report highlights the major area of Biochemical Reagents Market:

1. The research analysts elaborate on the Biochemical Reagents value chain and its distributor analysis in detail. This research study illustrates thorough information that improves the scope, application, and understanding of the Biochemical Reagents market. The world Biochemical Reagents Market report consists of an entire industry oveBiochemical Reagentsiew to provide consumers with a complete concept of the Biochemical Reagents market situation and its trends.

2. The extensive view of the Biochemical Reagents research is pursued by application, segmentation, and regional analysis of the market. This ensures that Biochemical Reagents clients get good knowledge about each section. It also explains facts about the worldwide Biochemical Reagents market and key pointers in terms of its growth and sales.

3. The report describes an in-depth analysis of the key Biochemical Reagents industry players coupled with the profiles and their tendency towards the market. That analyzes Biochemical Reagents Market price, cost, gross, revenue, specifications, product picture, company profile, and contact information.

4. The report comprehensively analyzes the Global Biochemical Reagents market status, supply, sales, and production. The Biochemical Reagents market shares of production and sales are evaluated along with the review of the production, capacity, sales, and revenue. Various aspects such as Biochemical Reagents import or export, price, gross margin, consumption, and cost are also analyzed. On the whole, the report covers the Biochemical Reagents market view and its growth probability for upcoming years.

5. The report also briefs all challenges and opportunities in the Biochemical Reagents market. The study discusses Biochemical Reagents market key events, new innovations, and top players strategies. The client gets wide knowledge and deep perceptive of Biochemical Reagents restraints, distinct drivers, and factors impacting the industry. So that they can plan their growth map of the Biochemical Reagents industry for the coming years.

Buy This Premium Report @https://www.eonmarketresearch.com/buy/72747

By Types:

Cell and Tissue Culture ReagentsChromatography ReagentsElectrophoresis ReagentsPolymerase Chain Reaction (PCR) Reagent KitsOther

By Applications:

HospitalsDiagnostic CentersAcademics and ResearchPharma and Biotech Companies

Covering Region:

1. South America Biochemical Reagents Market Covers Colombia, Brazil, and Argentina.2. North America Biochemical Reagents Market Covers Canada, United States, and Mexico.3. Europe Biochemical Reagents Market Covers UK, France, Italy, Germany, and Russia.4. The Middle East and Africa Biochemical Reagents Market Covers UAE, Saudi Arabia, Egypt, Nigeria, and South Africa.5. Asia Pacific Biochemical Reagents Market Covers Korea, Japan, China, Southeast Asia, and India.

Do Inquiry Before Purchasing Report Here and Ask For Discount @ https://www.eonmarketresearch.com/enquiry/72747

About Us:

Eon Market Research is the leading research company offering both tactical and strategic support to all our customers. Customer satisfaction is our goal and that is why, we have a team of skilled and experienced specialists with the ability to do data mining, information management, and revenue enhancement solutions to ensure that our clients make informed decisions when coming to investing in the market. Our happiness is when we help our clients grow their business, strengthen the brands and educate their members or consumers through the ever-new fun research methods developed by our team.

Contact Us:

Eon Market ResearchPhone: +1 703 879 7090Email: [emailprotected]

View post:
Global Biochemical Reagents Market Top Key Players, Regions, Type and Application Outlook Upto 2020 to 2025 - 3rd Watch News

June: epsrc-zerocarbon | News and features – University of Bristol

Chemists, biochemists and physicists at Bristol, Exeter and Sheffield have teamed up in a 7.25 million five-year project that could drive down the cost of energy production and help in the governments net zero carbon ambitions

The Engineering and Physical Sciences Research Council (EPSRC) has awarded funding for a programme designed to develop 'Molecular Photonic Breadboards'. These are organic molecular materials that it is hoped will enable highly efficient capture and transport of light energy.

Solar cells are powered by silicon semiconductors absorbing sunlight and converting that light into electricity. For organic materials to match the efficiency of silicon, scientists need to control the behaviour of excitons - formed when light is absorbed by molecules - much more effectively.

The project, led by Professor Graham Leggett, a chemist at the University of Sheffield. Professor Leggett said: "Control of excitons is essential for many new and emerging technologies identified in the government's Industrial Strategy as being vital to the economic success of the UK, including solar energy capture, photocatalysis, quantum technologies, and the design of diagnostic devices for personalised medicine.

"An unsolved grand challenge has been to develop design rules for the long-range transport of excitons. Our goal is to solve this grand challenge."

Bristols involvement centres on the Bristol BioDesign Institute and Professor Dek Woolfson's protein-design laboratory. Dek, who is Professor of Chemistry and Biochemistry, commented: "This is a really exciting project. For several years, we have been designing proteins from scratch mostly just to see if it could be done. This led to the discovery of a completely new class of proteins that we call alpha-helical barrels. Their unusual shapes make them ideal for applications of the type that will be explored in this collaboration with Graham and colleagues."

The 7.25 million grant includes 800,000 for the protein-design work at Bristol.

About Bristol BioDesign InstituteBristol BioDesign Institute (BBI)is the University of Bristol's Specialist Research Institute for synthetic biology. With wide-ranging applications from health to food security, BBI combines pioneering synthetic biology approaches with understanding biomolecular systems to deliver the rational design and engineering of biological systems for useful purposes.

This is delivered through multidisciplinary research that brings together postgraduate and postdoctoral researchers, academics, policy makers and industry, whilst also engaging the public with emerging solutions to global challenges.

See original here:
June: epsrc-zerocarbon | News and features - University of Bristol

University of East London lecturer says PHE report fails to address genetics – Newham Recorder

Video

PUBLISHED: 10:00 29 June 2020

Cash Boyle

Dr Winston Morgan, Reader in Toxicology and Clinical Biochemistry at the University of East London, says race and genetics are key omissions from the PHE report on coronavirus. Picture: University of East London

Archant

Email this article to a friend

To send a link to this page you must be logged in.

Dr Morgan a reader in toxicology and clinical biochemistry at the university commended the report for properly addressing the structural problems linked to racism which have caused Covid-19 to disproportionately impact BAME communities.

However, the lecturer criticised the complete lack of consideration given to the issue of genetics, and specifically to answering the question as to whether certain traits increase virus susceptibility.

Failing to adequately address this subject leaves the door open for continued speculation around race and genetics, said Dr Morgan.

This report was an opportunity to knock the speculation on its head, and allow for focus to be appropriately shifted to dealing with the damaging structural problems within society.

A spokesperson for PHE said: The review was not able to look at genetic factors and more research in this area is needed.

To complement the review, a research call by the National Institute for Health Research (NIHR) and UK Research and Innovation (UKRI) has jointly called for research proposals to investigate emerging evidence of an association between ethnicity and COVID-19 incidence and adverse health outcomes.

Dr Morgan also queried how the report framed its discussion of the relationship between the BAME community and the NHS: The report missed a number of opportunities, such as not to consider that historical racism will impact on both the speed and level of treatment BAME groups are likely to receive when they interact with the NHS.

Instead, it focused on the fact that as a result of historical racism BAME groups are less likely to seek care when needed.

Both arguments are underpinned by historical racism, and should have been given equal weight in the report: By omitting the former it has the feel of blaming the victims for not complaining.

PHE conceded that the report did not consider every issue: There are many impacts of systemic racism and PHEs qualitative report identified the issues that were raised repeatedly by stakeholders.

This does not mean that other factors are not relevant and confirms the need for further more detailed research studies on these issues.

Dr Morgan concluded that despite reservations over the lack of wider recommendation about tackling structural racism in wider society, all seven recommendations should be implemented.

If you value what this story gives you, please consider supporting the Newham Recorder. Click the link in the orange box below for details.

See the original post:
University of East London lecturer says PHE report fails to address genetics - Newham Recorder

Alberta businesswoman named lieutenant-governor, first Muslim in role in Canada – EverythingGP

She has mentored young students with English as a second language and helped steer a committee dedicated to helping vulnerable women gain access to education.

Lakhani was born inUganda andhas an honours degree in clinical biochemistry from the University of Manchester.

She has been in Edmonton for more than 40 years, owning and operating an early childhood education centre.

In 2005, she was awarded the Alberta Centennial Medal for outstanding achievementsin the province. And in2012, she was awarded the Queen Elizabeth Diamond Jubilee Medal honouring service to Canada.

Lieutenant-governors,the highest-ranking officers in each province, carry out a variety of official dutiesincludingswearing in the premier and cabinet, opening each session of the legislative assembly and signing bills into laws.

Ms. Lakhani is devoted to supporting people in her community, from new immigrants and young people, to women and families, Trudeau said in a news release Tuesday.

As lieutenant governor of Alberta, I know she will serve the people of her province and our country well, and continue to be a source of inspiration for all Canadians.

This report by The Canadian Press was first published June 30, 2020

The Canadian Press

Read more:
Alberta businesswoman named lieutenant-governor, first Muslim in role in Canada - EverythingGP

Biochemical Sensor Market Sales, Consumption, Demand and Forecast 2018-2025 – Cole of Duty

The competition prevailing in theglobal biochemical sensor marketis considerably high. As leading companies fight out for the lead in the market, product innovations and launches are on cards. Besides this, investments in research and development have scaled higher as market players aim for emerging at the fore. In order to boost operations, several players are concentrating on expanding their regional footprint, especially in Asia Pacific. Cheap labor, abundance of raw materials, and the rising demand from emerging nations make the region highly lucrative for investment, finds Trends market research(TMR) in a Recent study.

Request For Report[emailprotected]https://www.trendsmarketresearch.com/report/sample/3433

Some of the most prominent names in the global biochemical sensor market are GE Healthcare, Thermo Fisher Scientific, Honeywell International, Inc., Bio-Rad Laboratories, Inc., and Polestar Technologies, Inc., among others. Besides aforementioned strategies, many of the market players are also pushing mergers and acquisitions to capitalize on their expertise and expand their product portfolio.

Overall, the global biochemical sensor market will rise at a healthy CAGR of XX% by 2025. At this pace, the market is expected to reach US$XX bn by the end of 2025, from its valuation of US$XX bn in 2016. Based on product, electrochemical sensors constituted the leading segment with a share of XX% in 2016. Besides this, piezoelectric sensor, thermal sensor, gas sensor, and optical sensor make other key segments in terms of product.

Regionally, North America held dominant with a share of over XX% in the global market in 2018. Europe and Asia Pacific followed closely as the second- and third-leading markets for biochemical in the same year. However, over the course of the forecast period, North America is likely to lose its market share, while Asia Pacific and Europe markets will witness accelerated pace of gains.

Application across Diverse Industries, Especially Healthcare, to Boost Growth

As biochemical sensors have found a leading end user in the healthcare sector, growth witnessed in the industry will subsequently fuel their demand. The healthcare infrastructure is a major consideration by governments when planning economic growth. Over the years, the industry has expanded exponentially. Additionally, investments in research and development are forecast to increase in the coming years. Biochemical sensors are used in the qualitative and quantitative assessment of clinical diagnosis in the healthcare sector, said a lead TMR analyst. The increasing aging population, coupled with the rising incidence of chronic ailments, will fuel the demand for precise diagnosis, thus providing significant impetus to the biochemical sensor market, he added.

Besides this, government initiatives to ensure superior food quality, advancements in material chemistry and wireless networks, the rising demand for advanced wearable biochemical sensors, and the growing population of point of care diagnostics will create lucrative market opportunities. RRI also prophesized that the rising oil extraction worldwide will tip scales in favor of the market. Rise in oil extraction would result in greater percentage of inflammable and toxic in the air. Spurred by this, the use of biochemical sensors will increase to detect the presence of toxic gas.

Get COVID-19 Report[emailprotected]https://www.trendsmarketresearch.com/report/covid-19-analysis/3433

Originally posted here:
Biochemical Sensor Market Sales, Consumption, Demand and Forecast 2018-2025 - Cole of Duty

Biochemical Sensor Market Will Grow at CAGR During 2019-2025 Global Evaluation by Trends, Proportions, Share, Swot, and Key Developments – Cole of…

A new research study has been presented by UpMarketResearch.com offering a comprehensive analysis on the Global Biochemical Sensor Market where user can benefit from the complete market research report with all the required useful information about this market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. The report discusses all major market aspects with expert opinion on current market status along with historic data. This market report is a detailed study on the growth, investment opportunities, market statistics, growing competition analysis, major key players, industry facts, important figures, sales, prices, revenues, gross margins, market shares, business strategies, top regions, demand, and developments.

The Biochemical Sensor Market report provides a detailed analysis of the global market size, regional and country-level market size, segment growth, market share, competitive landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunity analysis, strategic market growth analysis, product launches, and technological innovations.

Get a Free Sample Copy of the Biochemical Sensor Market Report with Latest Industry Trends @ https://www.upmarketresearch.com/home/requested_sample/87715

Major Players Covered in this Report are: company 1company 2company 3company 4company 5company 6company 7company 8company 9

Global Biochemical Sensor Market SegmentationThis market has been divided into Types, Applications, and Regions. The growth of each segment provides an accurate calculation and forecast of sales by Types and Applications, in terms of volume and value for the period between 2020 and 2026. This analysis can help you expand your business by targeting qualified niche markets. Market share data is available on the global and regional level. Regions covered in the report are North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Research analysts understand the competitive strengths and provide competitive analysis for each competitor separately.

By Types:Type 1Type 2Type 3

By Applications:Application 1Application 2Application 3

To get Incredible Discounts on this Premium Report, Click Here @ https://www.upmarketresearch.com/home/request_for_discount/87715

Global Biochemical Sensor Market Regions and Countries Level AnalysisRegional analysis is a highly comprehensive part of this report. This segmentation sheds light on the sales of the Biochemical Sensor on regional- and country-level. This data provides a detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.

The report offers an in-depth assessment of the growth and other aspects of the market in key countries including the US, Canada, Mexico, Germany, France, the UK, Russia, Italy, China, Japan, South Korea, India, Australia, Brazil, and Saudi Arabia. The competitive landscape chapter of the global market report provides key information about market players such as company overview, total revenue (financials), market potential, global presence, Biochemical Sensor sales and revenue generated, market share, prices, production sites and facilities, products offered, and strategies adopted. This study provides Biochemical Sensor sales, revenue, and market share for each player covered in this report for a period between 2016 and 2020.

Make an Inquiry of this Report @ https://www.upmarketresearch.com/home/enquiry_before_buying/87715

Why Choose Us:

Table of Contents1. Executive Summary2. Assumptions and Acronyms Used3. Research Methodology4. Market Overview5. Global Market Analysis and Forecast, by Types6. Global Market Analysis and Forecast, by Applications7. Global Market Analysis and Forecast, by Regions8. North America Market Analysis and Forecast9. Latin America Market Analysis and Forecast10. Europe Market Analysis and Forecast11. Asia Pacific Market Analysis and Forecast12. Middle East & Africa Market Analysis and Forecast13. Competition Landscape

About UpMarketResearch:Up Market Research (https://www.upmarketresearch.com) is a leading distributor of market research report with more than 800+ global clients. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Contact Info UpMarketResearchName Alex MathewsEmail [emailprotected]Organization UpMarketResearchAddress 500 East E Street, Ontario, CA 91764, United States.

Original post:
Biochemical Sensor Market Will Grow at CAGR During 2019-2025 Global Evaluation by Trends, Proportions, Share, Swot, and Key Developments - Cole of...

Prevalence and Determinants of Hypertension Among Diabetic Patients in | DMSO – Dove Medical Press

Daba Abdissa,1 Kumsa Kene2

1Department of Biomedical Sciences Division of Clinical Anatomy, College of Medical Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia; 2Department of Biomedical Sciences Division of Medical Biochemistry, College of Medical Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia

Correspondence: Daba Abdissa Tel +251 923503701Email dhaabaa4@gmail.com

Purpose: Hypertension is a growing public health problem with a remarkable contribution to morbidity and mortality. It is a common condition which usually coexists with diabetes and aggravates its complications. The objective of this study was to assess the prevalence and determinants of hypertension among diabetic patients attending their follow-up at Jimma University Medical Center (JUMC) from June 1 to August 30, 2019.Methods: A hospital-based cross-sectional study was conducted in diabetic patients attending their follow-up at JUMC. Systematic random sampling and a pretested interviewer-administered structured questionnaire were used to collect information. Data were entered into EPI data 3.1 and exported to SPSS version 20. A variable having a p-value of < 0.25 in the bivariate model was subjected to multivariate analysis to avoid the confounding variables effect. Adjusted odds ratios were calculated at the 95% confidence interval and considered significant with a p-value of < 0.05.Results: A total of 366 diabetic patients were included in the study. Their mean age was 50.1 14.28 years, and the mean duration of diabetes was 6.8 5.3 years. The study finding showed that the prevalence of hypertension among diabetic patients was 37.4%. According to the multivariate logistic regression analysis, age of 50 years [AOR = 4.79; 95% CI: 1.4, 16.4], having body mass index (BMI) of 25 [AOR = 3.11; 95% CI: 1.58, 6.12] and khat chewing [AOR =19.34; 95% CI: 10.26, 36.44] were independent predictors of hypertension among diabetic patients.Conclusion: Our study found that there is high prevalence of hypertension among diabetic patients. Age of 50 years, having BMI of 25 kg/m2 and khat chewing were associated with hypertension among participants. Early detection and appropriate interventions should be an important action among patients with age 50 years, having BMI 25kg/m2 and khat chewers.

Keywords: prevalence, determinants, hypertension, diabetes, Southwest Ethiopia

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Go here to read the rest:
Prevalence and Determinants of Hypertension Among Diabetic Patients in | DMSO - Dove Medical Press

University Of Maryland Student Collects T-Shirts To Make Face Coverings For Those In Need During COVID-19 Pandemic – CBS Baltimore

COLLEGE PARK, Md. (WJZ) A rising senior at the University of Maryland, College Park is being recognized for her volunteer work through the COVID-19 pandemic.

The bioengineering major used social media to organize cloth drives to collect T-shirts for to make face coverings.

CORONAVIRUS COVERAGE:

Vaani Shah makes and delivers the masks to her local health department, which are then given out to frontline workers, COVID-19 patients and their visitors.

Since starting the project, hundreds of masks have been made and delivered.

Shah also volunteers at the Frederick Community Action Agency to help pack bags of food for families in need.

For the latest information on coronavirus go to theMaryland Health Departments websiteor call 211. You can find all of WJZs coverage oncoronavirus in Maryland here.

View post:
University Of Maryland Student Collects T-Shirts To Make Face Coverings For Those In Need During COVID-19 Pandemic - CBS Baltimore

Wearable-tech glove translates sign language into speech in real time – University of California

UCLA bioengineers have designed a glove-like device that can translate American Sign Language into English speech in real time though a smartphone app. Their research is published in the journal Nature Electronics.

Our hope is that this opens up an easy way for people who use sign language to communicate directly with non-signers without needing someone else to translate for them, said Jun Chen, an assistant professor of bioengineering at the UCLA Samueli School of Engineering and the principal investigator on the research. In addition, we hope it can help more people learn sign language themselves.

The system includes a pair of gloves with thin, stretchable sensors that run the length of each of the five fingers. These sensors, made from electrically conducting yarns, pick up hand motions and finger placements that stand for individual letters, numbers, words and phrases.

The device then turns the finger movements into electrical signals, which are sent to a dollar-coinsized circuit board worn on the wrist. The board transmits those signals wirelessly to a smartphone that translates them into spoken words a the rate of about a one word per second.

The researchers also added adhesive sensors to testers faces in between their eyebrows and on one side of their mouths to capture facial expressions that are a part of American Sign Language.

Previous wearable systems that offered translation from American Sign Language were limited by bulky and heavy device designs or were uncomfortable to wear, Chen said.

The device developed by the UCLA team is made from lightweight and inexpensive but long-lasting, stretchable polymers. The electronic sensors are also very flexible and inexpensive.

In testing the device, the researchers worked with four people who are deaf and use American Sign Language. The wearers repeated each hand gesture 15 times. A custom machine-learning algorithm turned these gestures into the letters, numbers and words they represented. The system recognized 660 signs, including each letter of the alphabet and numbers 0 through 9.

In addition to Chen, the studys UCLA authors are co-lead author Zhihao Zhao, Kyle Chen, Songlin Zhang, Yihao Zhou and Weili Deng. All are members of Chens Wearable Bioelectronics Research Group at UCLA. The other corresponding author is Jin Yang, of Chinas Chongqing University.

UCLA has filed for a patent on the technology. A commercial model based on this technology would require added vocabulary and an even faster translation time, Chen said.

Excerpt from:
Wearable-tech glove translates sign language into speech in real time - University of California

LED Lighting for Horticulture Application Market Report 2020: Acute Analysis of Global Demand and Supply 2026 with Major Key Player: Cree, LumiGrow,…

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the LED Lighting for Horticulture ApplicationMarket which would mention How the Covid-19 is Affecting the Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Key Regions and Proposal for LED Lighting for Horticulture Application Market Players to battle Covid-19 Impact.

The LED Lighting for Horticulture ApplicationMarket report is one of the most comprehensive and important data about business strategies, qualitative and quantitative analysis of Global Market. It offers detailed research and analysis of key aspects of the LED Lighting for Horticulture Application market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the LED Lighting for Horticulture Application market.

Top Leading players covered in the LED Lighting for Horticulture Application market report: Cree, LumiGrow, Hubbell Lighting, Fluence Bioengineering, Lemnis Oreon, Heliospectra, Smart Grow Technologies, Kessil Lighting, Illumitex, Osram Sylvania and More

Get PDF Sample Report With Impact of COVID-19 on LED Lighting for Horticulture Application [emailprotected] https://www.marketinforeports.com/Market-Reports/Request-Sample/91292

The report offers clear guidelines for players to cement a position of strength in the global LED Lighting for Horticulture Application market. It prepares them to face future challenges and take advantage of lucrative opportunities by providing a broad analysis of market conditions. the global LED Lighting for Horticulture Application market will showcase a steadyCAGR in the forecast year 2020 to 2026.

Market Segment by Type covers:LED LampLED Luminaire

Market Segment By Application covers:Commercial greenhouseIndoor and vertical farming

Our Complimentary Sample LED Lighting for Horticulture Application market Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology.

Inquire and Get Up to 30% DiscountBy Clicking Here!https://www.marketinforeports.com/Market-Reports/Request_discount/91292

Regions Covered in the Global LED Lighting for Horticulture Application Market: The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Years Considered to Estimate the LED Lighting for Horticulture Application Market Size:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year: 2020-2026

Highlights of the Report: Accurate market size and CAGR forecasts for the period 2019-2026 Identification and in-depth assessment of growth opportunities in key segments and regions Detailed company profiling of top players of the global LED Lighting for Horticulture Application market Exhaustive research on innovation and other trends of the global LED Lighting for Horticulture Application market Reliable industry value chain and supply chain analysis Comprehensive analysis of important growth drivers, restraints, challenges, and growth prospects

For More Information:https://www.marketinforeports.com/Market-Reports/91292/LED-Lighting-for-Horticulture-Application-market

Customization of the Report:Market Info Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Get Customization of the [emailprotected]:https://www.marketinforeports.com/Market-Reports/Request-Customization/91292/LED-Lighting-for-Horticulture-Application-market

Contact Us:Mr. Marcus KelCall: +1 415 658 9988 (International)+91 84 839 65921 (IND)Email: [emailprotected]Website: http://www.marketinforeports.com

Go here to read the rest:
LED Lighting for Horticulture Application Market Report 2020: Acute Analysis of Global Demand and Supply 2026 with Major Key Player: Cree, LumiGrow,...